216 related articles for article (PubMed ID: 7753331)
1. Further studies in deoxycorticosterone acetate treated rats: brain content of mineralocorticoid and glucocorticoid receptors and effect of steroid antagonists on salt intake.
Vallee SM; Grillo CA; Gonzalez S; Cosen-Binker L; de Kloet ER; McEwen BS; De Nicola AF
Neuroendocrinology; 1995 Feb; 61(2):117-24. PubMed ID: 7753331
[TBL] [Abstract][Full Text] [Related]
2. Intracerebral administration of mineralocorticoid receptor antisense oligonucleotides attenuate adrenal steroid-induced salt appetite in rats.
Sakai RR; Ma LY; Zhang DM; McEwen BS; Fluharty SJ
Neuroendocrinology; 1996 Dec; 64(6):425-9. PubMed ID: 8990075
[TBL] [Abstract][Full Text] [Related]
3. The amygdala: site of genomic and nongenomic arousal of aldosterone-induced sodium intake.
Sakai RR; McEwen BS; Fluharty SJ; Ma LY
Kidney Int; 2000 Apr; 57(4):1337-45. PubMed ID: 10760064
[TBL] [Abstract][Full Text] [Related]
4. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
[TBL] [Abstract][Full Text] [Related]
5. Changes in Fos expression in various brain regions during deoxycorticosterone acetate treatment: relation to salt appetite, vasopressin mRNA and the mineralocorticoid receptor.
Pietranera L; Saravia FE; McEwen BS; Lucas LL; Johnson AK; De Nicola AF
Neuroendocrinology; 2001 Dec; 74(6):396-406. PubMed ID: 11752896
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint.
Calvo N; Volosin M
Neuroendocrinology; 2001 Apr; 73(4):261-71. PubMed ID: 11340340
[TBL] [Abstract][Full Text] [Related]
7. Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats.
Van den Berg DT; de Kloet ER; de Jong W
Am J Physiol; 1994 Dec; 267(6 Pt 1):E927-33. PubMed ID: 7810636
[TBL] [Abstract][Full Text] [Related]
8. Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?
Rickard AJ; Funder JW; Morgan J; Fuller PJ; Young MJ
Endocrinology; 2007 Oct; 148(10):4829-35. PubMed ID: 17640982
[TBL] [Abstract][Full Text] [Related]
9. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation.
Ratka A; Sutanto W; Bloemers M; de Kloet ER
Neuroendocrinology; 1989 Aug; 50(2):117-23. PubMed ID: 2550833
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of magnocellular vasopressin mRNA in rats with deoxycorticosterone-acetate induced salt appetite.
Grillo CA; Saravia F; Ferrini M; Piroli G; Roig P; García SI; de Kloet ER; De Nicola AF
Neuroendocrinology; 1998 Aug; 68(2):105-15. PubMed ID: 9705577
[TBL] [Abstract][Full Text] [Related]
11. Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary.
Reul JM; de Kloet ER; van Sluijs FJ; Rijnberk A; Rothuizen J
Endocrinology; 1990 Aug; 127(2):907-15. PubMed ID: 2164924
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of RU28318 and RU40555 as selective mineralocorticoid receptor and glucocorticoid receptor antagonists, respectively: receptor measures and functional studies.
Kim PJ; Cole MA; Kalman BA; Spencer RL
J Steroid Biochem Mol Biol; 1998 Nov; 67(3):213-22. PubMed ID: 9879980
[TBL] [Abstract][Full Text] [Related]
13. Effect of serotonin inhibition on glucocorticoid and mineralocorticoid expression in various brain structures.
Semont A; Fache M; Ouafik L; Hery M; Faudon M; Hery F
Neuroendocrinology; 1999 Feb; 69(2):121-8. PubMed ID: 9986925
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats.
Smythe JW; Murphy D; Timothy C; Costall B
Pharmacol Biochem Behav; 1997 Mar; 56(3):507-13. PubMed ID: 9077590
[TBL] [Abstract][Full Text] [Related]
15. Na/H exchange isoform 1 is involved in mineralocorticoid/salt-induced cardiac injury.
Fujisawa G; Okada K; Muto S; Fujita N; Itabashi N; Kusano E; Ishibashi S
Hypertension; 2003 Mar; 41(3):493-8. PubMed ID: 12623949
[TBL] [Abstract][Full Text] [Related]
16. The role of the glucocorticoid receptor in mineralocorticoid/salt-mediated cardiac fibrosis.
Rickard AJ; Funder JW; Fuller PJ; Young MJ
Endocrinology; 2006 Dec; 147(12):5901-6. PubMed ID: 16990342
[TBL] [Abstract][Full Text] [Related]
17. Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes.
Amador CA; Barrientos V; Peña J; Herrada AA; González M; Valdés S; Carrasco L; Alzamora R; Figueroa F; Kalergis AM; Michea L
Hypertension; 2014 Apr; 63(4):797-803. PubMed ID: 24420551
[TBL] [Abstract][Full Text] [Related]
18. Changes of hypothalamic and plasma vasopressin in rats with deoxycorticosterone-acetate induced salt appetite.
Saravia FE; Grillo CA; Ferrini M; Roig P; Lima AE; de Kloet ER; De Nicola AF
J Steroid Biochem Mol Biol; 1999; 70(1-3):47-57. PubMed ID: 10529002
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid- and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids.
Tanaka J; Fujita H; Matsuda S; Toku K; Sakanaka M; Maeda N
Glia; 1997 May; 20(1):23-37. PubMed ID: 9145302
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid and mineralocorticoid receptors regulate paracellular permeability in a primary cultured gill epithelium.
Kelly SP; Chasiotis H
J Exp Biol; 2011 Jul; 214(Pt 14):2308-18. PubMed ID: 21697422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
